Overview

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 149-164

  Bönisch, Heinz ^a   Eiden, Lee ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008347842     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60717-6     Document Type: Article

References (46)

1. Takahashi N., Miner L., Sora I., Ujike H., Revay R., Kostic V., Jackson-Lewis L., Przedborski S., and Uhl G. VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion and enhanced MPTP toxicity. Proc. Natl. Acad. Sci. USA. (1997) in press
2. Guastella J., Nelson N., Nelson H., Czyk L., Keynan S., Miedel M., Davidson N., Lester H., and Kanner B. Cloning and expression of a rat brain G ABA transporter. Science 249 (1990) 1303-1306
3. Amara S.G., and Kuhar M.J. Neurotransmitter transporters: Recent progress. Annu. Rev. Neurosci. 16 (1993) 73-93
4. Borowsky B., and Hoffman B. Neurotransmitter transporters: Molecular biology, function, and regulation. Int. Rev. Neurobiol. 38 (1995) 139-199
5. Brüss M., Hammermann R., Brimijoin S., and Bönisch H. Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J. Biol. Chem. 270 (1995) 9197-9291
6. Pacholczyk T., Blakely R.D., and Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350 (1991) 350-354
7. Lingen B., Brüss M., and Bönisch H. Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter. FEBS Lett. 342 (1994) 235-238
8. Brüss M., Pörzgen P., Bryan-Lluka L.J., and Bönisch H. Cloning of the (uptakel) noradrenaline transporter from PC12 cells. Naunyn Schmiedebergs Arch. Pharmacol. 355 suppl (1997) R27
9. Larong D., Amara S.G., and Simerly R.B. Cell-type specific expression of catecholamine transporters in the rat brain. J. Neurosci. 14 (1993) 4903-4914
10. Graefe K.H., and Bönisch H. The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurones. In: Trendelenburg U., and Weiner N. (Eds). Handbook of Experimental Pharmacology, 90/1 (1988), Springer-Verlag, Berlin, Heidelberg, New York 193-245
11. Iversen L.L. The Uptake and Storage of Noradrenaline in Sympathetic Nerves (1967), Cambridge University Press, Cambridge
12. Paton D.M. The Mechanism of Neuronal and Extraneuronal Transport of Catecholamines (1976), Raven Press, New York
13. Meiergerd S.M., and Schenk J.O. Striatal transporters for dopamine: Catechol structure-activity studies und susceptibility to chemical modification. J. Neurochem. 63 (1994) 1683-1692
14. Burnette W.B., Bailey M.D., Kukoyi S., Blakely R.D., Trowbridge C.G., and Justice J.B. Investigation of human norepinephrine transporter kinetics using rotating disk electrode voltametry. Anal. Chem. 68 (1996) 2932-2938
15. Bönisch H. The transport of (+)amphetamine by the neuronal noradrenaline carrier. Naunyn Schmiedebergs Arch. Pharmacol. 327 (1984) 267-272
16. Wall S.C., Gu H.H., and Rudnick G. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol. Pharmacol. 47 (1995) 544-550
17. Harder R., and Bönisch H. Effect of monovalent ions on the transport of noradrenaline across the plasma membrane of neuronal cells (PC 12 cells). J. Neurochem. 45 (1985) 1154-1162
18. Gu H.H., Wall S., and Rudnick G. Ion coupling stoichiometry for the norepineph rine transporter in membrane vesicles from stably transfected cells. J. Biol. Chem. 271 (1996) 6911-6916
19. Sonders M.S. Characterization of two steady-state conductances mediated by the electrogenic human dopamine transporter. Biophys. J. 70 (1996) A98
20. Cass W.A., and Gerhardt G.A. Direct evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176 (1994) 259-263
21. Galli A., DeFelice L.J., Duke B.J., Moore K.R., and Blakely R.D. Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J. Exp. Biol. 198 (1995) 2197-2212
22. DeFelice L.J., and Blakely R.D. Pore models for transporters. Biophys. J. 70 (1996) 579-580
23. Sonders M., and Amara S.G. Channels in transporters. Curr. Opin. Neurobiol. 2 (1996) 294-302
24. Nguyen T.T., and Amara S.G. N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition. J. Neurochem. 67 (1996) 645-655
25. Melikian H.E., Ramamoorthy S., Tate C.G., and Blakely R.D. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol. Pharmacol. 50 (1996) 266-276
26. Kitayama S., Dohi T., and Uhl R.G. Phorbol esters alter functions of the expressed dopamine transporter. Eur. J. Pharmacol. 268 (1994) 115-119
27. Kadowaki K., Hirota K., Koike K., Ohmichi M., Kiyama H., Miyake A., and Tanizawa O. Adenosine 3′,5′-cyclic monophosphate enhances dopamine accumulation in rat hypothalamic cell cultures containing dopaminergic neurons. Neuroendocrinology 52 (1990) 256-261
28. Perrone-Capano C., Tino A., Amadoro G., Pernas-Alonso R., and DiPorzio U. Dopamine transporter gene expression in rat mesencephalic dopaminergic neurons is in creased by direct interaction with target striatal cells in vitro. Mol. Brain Res. 39 (1996) 160-166
29. Lew R., Vaughan R., Simantov R., Wilson A., and Kuhar J.M. Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights. Synapse 8 (1991) 152-153
30. Jones R.S., Garris A.P., Kilts D.C., and Wightman M.R. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J. Neurochem. 64 (1995) 2581-2589
31. Marino V., DeLaLande I.S., Parker D.A.S., Dally J., and Wing S. Extraneuronal uptake of noradrenaline in rabbit dental pulp: Evidence of identity with uptake1. Naunyn Schmiedebergs Arch. Pharmacol. 346 (1992) 166-172
32. DeLaLande I.S.V., Marino V., Kennedy J.A., Parker D.A., and Seamark R.F. Distribution of extraneuronal uptake, in reproductive tissues: Studies on cells in culture. J. Neural. Transm. Suppl. 34 suppl (1991) 37-42
33. Ramamoorthy S., Prasad P.D., Kulanthailev P., Leibach F.H., Blakely R.D., and Ganapathy V. Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast. Biochemistry 32 (1993) 1346-1353
34. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
35. Hillarp N.A. Isolation and some biochemical properties of the catechol amine granules in the cow adrenal medulla. Acta Physiol. Scand. 43 (1958) 82-96
36. Winkler H., and Westhead E. The molecular organization of adrenal chromaffin granules. Neuroscience 5 (1980) 1803-1823
37. Winkler H., and Fischer-Colbrie R. The chromogranins A and B: The first 25 years and future perspectives. Neuroscience 49 (1992) 497-528
38. Schuldiner S. A molecular glimpse of vesicular transporters. J. Neurochem. 62 (1994) 2067-2078
39. Peter D., Liu Y., Sternini C., de Giorgio R., Brecha N., and Edwards R.H. Differential expression of two vesicular monoamine transporters. J. Neurosci. 15 (1995) 6179-6188
40. Weihe E., Schäfer M.-H., Erickson J.D., and Eiden L.E. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J. Mol. Neurosci. 5 (1994) 149-164
41. Mahata S.K., Wu H., Mahata M., Minth-Worby C., Parmer R.J., and O'Connor D.T. Acquisition of peptidergic phenotypes by catecholamine storage vesicles: Cis and trans signaling determinants. Exp. Neurol. (1997) in press
42. MacArthur L., and Eiden L.E. Neuropeptide genes: Targets of activity-dependent signal transduction. Peptides 17 (1996) 721-728
43. Bauerfeind R., Jelinek R., Hellwig A., and Hüttner W.B. Neurosecretory vesicles can be hybrids of synaptic vesicles and secretory granules. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7342-7346
44. De Potter W.P., Partoens P., Schoups A., Llona I., and Coen E.P. Noradrenergic neurons release both noradrenaline and neuropeptide Y from a single pool: The large dense cored vesicles. Synapse 25 (1997) 44-55
45. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
46. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A.A., Lambert G., Kaye D.M., Kopin I.J., Goldstein D.S., and Esler M.D. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93 (1996) 1667-1676